A new CEOs at Merck & Co and Pfizer – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new CEOs at Merck & Co and Pfizer.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new CEOs at Merck & Co and Pfizer.
Drafting ICH M7 guidance on genotoxic impurities will require a lot of work from industry and regulators but has the potential to resolve a number of issues.
Australian Pharmaceutical Industries (API) and Sigma Pharmaceuticals shares’ have been hit by Pfizer’s decision to abandon wholesale distributors in favour of selling drugs direct to pharmacies.
Lanxess has opened an ion exchange resin production facility in India to cater for growing pharmaceutical manufacturing sector demand for ultrapure water.
Advinus Therapeutics is to use Corning Epic label-free detection to provide clients in India and abroad with biologically relevant drug discovery data.
G-Con Manufacturing and GE Healthcare plan to collaborate on development of modular portable bio-process production technology.
Parexel has opened clinical logistics services facilities in Singapore and Russia to meet increasing demand for support in the emerging regions.